Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Milton S. Hershey Medical Center
Incyte Corporation
Incyte Corporation
NRG Oncology
Kymab Limited
Shattuck Labs, Inc.
Incyte Corporation
Sarcoma Oncology Research Center, LLC
Stanford University
Novartis
AstraZeneca
Pfizer
Pfizer
ADC Therapeutics S.A.
Pfizer
Eli Lilly and Company
Bayer
University of Florida
Hoffmann-La Roche
Genmab
City of Hope Medical Center
Nektar Therapeutics
Nektar Therapeutics
Ludwig Institute for Cancer Research
Incyte Corporation
Pfizer
Five Prime Therapeutics, Inc.
Calithera Biosciences, Inc
Incyte Corporation
EMD Serono
Gilead Sciences
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Incyte Corporation
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Eli Lilly and Company
Stanford University
Pfizer
Ipsen
Butler Hospital
University of Kansas Medical Center
Beth Israel Deaconess Medical Center
GlaxoSmithKline
Roswell Park Cancer Institute
GlaxoSmithKline
Roswell Park Cancer Institute
Fox Chase Cancer Center
National Institutes of Health Clinical Center (CC)